InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: None

Tuesday, 01/02/2018 5:01:35 PM

Tuesday, January 02, 2018 5:01:35 PM

Post# of 9942
InMed is looking to cannabinoids that could accomplish analogous disease-fighting outcomes without any dangerous physical addiction like opiates. It is highly likely there will be a switch in the future to cannabinoid pain relievers from the use of opioid pain reliever such as oxycodone and hydrocodone that have been accompanied by an increased rate of opioid abuse and addiction. The medical pain market is huge.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News